Somatostatin-related therapeutics in ophthalmology: a review

T Missotten, G S Baarsma, R W A M Kuijpers, L I van den Born, T van der Loos, R Croxen, L J Hofland, P M van Hagen

Research output: Contribution to journalReview articlepeer-review


Somatostatin and its derivatives have been predominantly studied and succesfully used in endocrinological diseases. This article reviews the rationale of the use of somatostatin and its derivatives in ophthalmology based on current understanding of its action in the eye and summarizes previously published controlled studies and case series. The article points out future possible applications. Larger randomised controlled studies are necessary to confirm its current and future use. New ways of application could facilitate its broader use in ophthalmology.

Original languageEnglish
Pages (from-to)118-26
Number of pages9
JournalJournal of Endocrinological Investigation
Issue number11 Suppl International
Publication statusPublished - 2005


  • Angiogenesis Inhibitors
  • Anti-Inflammatory Agents
  • Cell Division
  • Eye/blood supply
  • Eye Diseases/drug therapy
  • Humans
  • Ophthalmology
  • Receptors, Somatostatin/analysis
  • Retinal Diseases/drug therapy
  • Somatostatin/analogs & derivatives


Dive into the research topics of 'Somatostatin-related therapeutics in ophthalmology: a review'. Together they form a unique fingerprint.

Cite this